REPIRAPATH IMMUNOCOMPROMISED Trademark

Trademark Overview

On Monday, September 10, 2018, a trademark application was filed for REPIRAPATH IMMUNOCOMPROMISED with the United States Patent and Trademark Office. The USPTO has given the REPIRAPATH IMMUNOCOMPROMISED trademark a serial number of 88110478. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, October 1, 2019. This trademark is owned by North Central Florida Neurodiagnostic Services Limited Liability Company. The REPIRAPATH IMMUNOCOMPROMISED trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical laboratory services
repirapath immunocompromised

General Information

Serial Number88110478
Word MarkREPIRAPATH IMMUNOCOMPROMISED
Filing DateMonday, September 10, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, October 1, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Disclaimer with Predetermined Text"IMMUNOCOMPROMISED"
Goods and ServicesMedical laboratory services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 17, 2018
Primary Code042
First Use Anywhere DateMonday, May 8, 2017
First Use In Commerce DateMonday, May 8, 2017

Trademark Owner History

Party NameNorth Central Florida Neurodiagnostic Services Limited Liability Company
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAlachua, FL 32615

Trademark Events

Event DateEvent Description
Wednesday, October 2, 2019ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, October 1, 2019ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, February 26, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, February 26, 2019FINAL REFUSAL E-MAILED
Tuesday, February 26, 2019FINAL REFUSAL WRITTEN
Friday, February 8, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 8, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 6, 2019TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, February 4, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 4, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, February 3, 2019ASSIGNED TO LIE
Tuesday, January 29, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 20, 2018NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Thursday, December 20, 2018EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Thursday, December 20, 2018COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Thursday, December 20, 2018EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Wednesday, December 19, 2018ASSIGNED TO EXAMINER
Monday, September 17, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 13, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

immunocompromised repirapath services laboratory medical